That $150 jump is worth a phone call. Ask UHC if the Lilly savings card still stacks, most commercial plans allow it and it can drop you back to $25. On the compounder math, your $150 gets you the drug and someone to sue if it goes wrong. The $200 got you powder from a factory nobody inspected. Price was low because the oversight was.
All I can say is, my PCP had no trouble even getting me started on Trulicity--a different GLP-1 inhibitor than semaglutide--since I've been diagnosed with Type-2 diabetes for more than a decade, during which time I was taking Levemir, and more recently Lantus, now that Novo-Nordisk has decided to discontinue distributing Levemir in the U…
Mar 6
at
8:15 PM
Relevant people
Log in or sign up
Join the most interesting and insightful discussions.